BTLS — Biotalys NV Share Price
Last trade - 00:00- €118.78m
- €98.88m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.3 | ||
| Price to Tang. Book | 4.39 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -42.19% | ||
| Return on Equity | -49.6% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | n/a | n/a | n/a | n/a | n/a | 2 | 2.5 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Biotalys NV (formerly Agrosavfe NV) is a Belgium-based Food and Crop Protection company that provides agricultural solutions. AGROBODY Foundry is a product of this company that provides crop protection products, based on active ingredients in combination with Agrobodies as formulation agents. It develops technology for sustainable crop protection. It offers tools to prevent crop loss while extending post-harvest protection and reducing food waste. This company provides protein-based biocontrol solutions. Biotalys allows biocontrol solutions to tackle a wide range of crop pests and diseases. This company has built a product pipeline against key pests and diseases known as EvocaTM. It also has a range of products pipeline of BioFungicides, BioInsecticides and BioBactericides.
Directors
- Lieven De Smedt CHM
- Patrice Selles CEO
- Wim Ottevaere CFO
- Patrick Mcdonnell OTH
- Patrick Van Beneden NED (59)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 7th, 2013
- Public Since
- July 2nd, 2021
- No. of Employees
- 63
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Euronext - Brussels
- Shares in Issue
- 37,470,062
- Address
- Buchtenstraat 11, GENT, 9051
- Web
- https://biotalys.com/
- Phone
- +32 92745400
- Auditors
- Deloitte Bedrijfsrevisoren
Upcoming Events for BTLS
Similar to BTLS
Cumulex NV
Euronext - Brussels
Greenyard NV
Euronext - Brussels
Lotus Bakeries NV
Euronext - Brussels
Miko NV
Euronext - Brussels
Sipef NV
Euronext - Brussels
FAQ
As of Today at 19:36 UTC, shares in Biotalys NV are trading at €3.17. This share price information is delayed by 15 minutes.
Shares in Biotalys NV last closed at €3.17 and the price had moved by +3.93% over the past 365 days. In terms of relative price strength the Biotalys NV share price has outperformed the FTSE Global All Cap Index by +1.33% over the past year.
The overall consensus recommendation for Biotalys NV is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreBiotalys NV does not currently pay a dividend.
Biotalys NV does not currently pay a dividend.
Biotalys NV does not currently pay a dividend.
To buy shares in Biotalys NV you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €3.17, shares in Biotalys NV had a market capitalisation of €118.78m.
Here are the trading details for Biotalys NV:
- Country of listing: Belgium
- Exchange: BRU
- Ticker Symbol: BTLS
Based on an overall assessment of its quality, value and momentum Biotalys NV is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Biotalys NV is €6.50. That is 105.05% above the last closing price of €3.17.
Analysts covering Biotalys NV currently have a consensus Earnings Per Share (EPS) forecast of -€0.81 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biotalys NV. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -0.76%.
As of the last closing price of €3.17, shares in Biotalys NV were trading +0.46% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Biotalys NV PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €3.17.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Biotalys NV's management team is headed by:
- Lieven De Smedt - CHM
- Patrice Selles - CEO
- Wim Ottevaere - CFO
- Patrick Mcdonnell - OTH
- Patrick Van Beneden - NED